Email updates

Keep up to date with the latest news and content from Journal of Medical Case Reports and BioMed Central.

Open Access Highly Accessed Case report

Fatal invasive cervical cancer secondary to untreated cervical dysplasia: a case report

Stephan Braun1, Daniel Reimer1, Isolde Strobl1, Ulrike Wieland2, Petra Wiesbauer1, Elisabeth Müller-Holzner1, Siegfried Fessler1, Arthur Scherer3, Christian Marth1 and Alain G Zeimet1*

Author Affiliations

1 Department of Obstetrics and Gynecology, Innsbruck Medical University, Anichstrasse 35, AT-6020 Innsbruck, Austria

2 Institute of Virology, University of Cologne, Fürst-Prückler-Strasse 65, D-50935 Cologne, Germany

3 Department of Obstetrics and Gynecology, Medical Services Hospital, Bressanone, Italy

For all author emails, please log on.

Journal of Medical Case Reports 2011, 5:316  doi:10.1186/1752-1947-5-316

Published: 18 July 2011

Abstract

Introduction

Well-documented cases of untreated cervical intra-epithelial dysplasia resulting in fatal progression of invasive cervical cancer are scarce because of a long pre-invasive state, the availability of cervical cytology screening programs, and the efficacy of the treatment of both pre-invasive and early-stage invasive lesions.

Case presentation

We present a well-documented case of a 29-year-old Caucasian woman who was found, through routine conventional cervical cytology screening, to have pathologic Papanicolaou (Pap) grade III D lesions (squamous cell abnormalities). She subsequently died as a result of human papillomavirus type 18-associated cervical cancer after she refused all recommended curative therapeutic procedures over a period of 13 years.

Conclusion

This case clearly demonstrates a caveat against the promotion and use of complementary alternative medicine as pseudo-immunologic approaches outside evidence-based medicine paths. It also demonstrates the impact of the individualized demands in diagnosis, treatment and palliative care of patients with advanced cancer express their will to refuse evidence-based treatment recommendations.